
As Clinical Research Associate and freelance clinical research consultant with strong experience in global Phase I to Phase III clinical trials.
🧪 I specialize in oncology, CAR T cell therapy, cardiology, and autoimmune disease studies. My expertise includes site monitoring, risk based monitoring, regulatory compliance, and clinical data quality management in line with ICH GCP standards.
🏥 My career began as a Site Coordinator at Medex SMO and continued with CRA and Senior CRA roles at Medex CRO, IQVIA, and Ascot Science, contributing to high impact Phase II and Phase III clinical trials.
🚀 Currently, I work as an independent freelance CRA and clinical research consultant, supporting CROs, sponsors, investigator sites, and biotech companies with study startup, site readiness, remote and on site monitoring, audit readiness, and GCP compliance consulting.
🎓 I am also a PhD candidate in Biology, with a strong academic background in genomics, bioinformatics, and omics based research, combining scientific depth with operational excellence.
🌍 Open to freelance, remote, and project based collaborations worldwide.
Clinical Research Experience

🧪 Scientific Trust and Operational Excellence in Clinical Research

PHASE 1
-
2022-2023: DC25-1A CAR-T (Phase I/IIa) Multiple Myeloma - Clinical Research Associate (CRA)
-
2023-Present: MG-001 (Phase Ib/II) - Clinical Research Associate 2

PHASE 3
-
2023-Present: PZN-127-03 (Phase III) - Clinical Research Associate 2
-
2023-2023: Horizon01 – Lung Cancer (Phase III) - Clinical Research Associate 2
-
2023-2023: INOVA 120-WO41554 Breast Cancer (Phase III) - Clinical Research Associate 2
-
2021-2023: I6T-MC-AMAM - Crohn Disease (Phase III) - Site Coordinator
-
2021-2023: I6T-MC-AMAX - Crohn Disease (Phase III) - Site Coordinator
-
2021-2023: GA29145 (Phase III) - Site Coordinator
-
2021-2023: APD334-303 (Phase III) - Site Coordinator
-
2021-2022: APD334-302 (Phase III) - Site Coordinator
.png)
PHASE 2
-
2024-Present: DC08-SLE-001 CAR-T (Phase IIa) - Clinical Research Associate 2
-
2023-2024: Intercept 747-214 (Phase IIa) - Clinical Research Associate 2
-
2022-2023: DC-08 CAR-T (Phase II) - Clinical Research Associate (CRA)
-
2020-2021: B7981007 (Phase II) - Site Coordinator
-
2020-2021: B7981005 (Phase II) - Site Coordinator
-
2021-2023: APD334-202 (Phase II) - Site Coordinator
PHASE 3
-
2021-2022: 261203 (Phase III) - Site Coordinator
-
2021-2023: HS0003 (Phase III) - Site Coordinator
-
2021-2023: TCH-306 (Phase III) - Site Coordinator
-
2021-2021: HS-18-633 (Phase III) - Site Coordinator
-
-
2021-2021: HS-19-647 (Phase III) - Site Coordinator
-
2020-2023: C3601002 (Phase III) - Site Coordinator
-
-
2020-2022: CT-P13_3.8 (Phase III) - Site Coordinator
-
2019-2023: AR-301 (Phase III) - Site Coordinator
-
2018-2021: ALX0681-C301 (HERCULES) (Phase III) - Site Coordinator
-
2023-Present: MG-001 (Phase Ib/II) - Clinical Research Associate 2
_edited.jpg)
Frequently asked questions
- 01
- 02
- 03
- 04
- 05






